Literature DB >> 11393670

Homozygosity for angiotensinogen 235T variant increases the risk of myocardial infarction in patients with multi-vessel coronary artery disease.

O Olivieri1, C Stranieri, D Girelli, F Pizzolo, S Grazioli, C Russo, P F Pignatti, R Corrocher.   

Abstract

OBJECTIVE: Molecular variants of the angiotensinogen (AGT) and the angiotensin II type 1 receptor (ATR) genes have been associated with the risk of coronary artery disease (CAD) and myocardial infarction (MI), but data so far available are conflicting. The primary object of the paper is to verify this possible association by a rigorous, angiographically controlled study in a large sample of patients with or without multi-vessel CAD.
DESIGN: We designed a large case-control study in Italian patients candidates for coronary artery bypass grafting, with angiographically documented multi-vessel CAD, compared to subjects with angiographically documented normal coronary arteries. METHODS AND
RESULTS: AGT M235T and ATR A1166C gene polymorphisms were analysed in 699 subjects; 454 patients were candidates for coronary artery bypass grafting, having angiographically documented (mainly multi-vessel) CAD. An appropriate documentation of previous MI was obtained from 404/454 (89%, 247 with and 157 without MI). Subjects (n = 245) with angiographically documented normal coronary arteries, were included as control group (CAD-free group). CAD patients had a substantial burden of conventional risk factors as compared with controls free of coronary atherosclerosis. Age, gender, smoking habit and number of stenosed vessels were the only differences between patients with or without previous myocardial infarction, who were similarly exposed to the other conventional risk factors (including hypertension). AGT M235T and ATR A1166C allele and genotype frequencies were similar between CAD and CAD-free patients. In the CAD group, AGT 235T allele was found more frequently in subjects with a previous myocardial infarction (0.494 versus 0.414; P < or = 0.05). By logistic regression, homozygosity for AGT 235T variant appeared to confer 1.9-fold increased risk for MI in both the univariate and the multivariate (adjusted for age, gender, smoking habit and number of stenosed vessels) model.
CONCLUSIONS: AGT 235 T homozygous patients with multivessel CAD have an increased risk of myocardial infarction as compared with subjects with clinically similar phenotype but different genotype.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11393670     DOI: 10.1097/00004872-200105000-00007

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  Heritability of carotid intima-media thickness: a twin study.

Authors:  Jinying Zhao; Faiz A Cheema; J Douglas Bremner; Jack Goldberg; Shaoyong Su; Harold Snieder; Carisa Maisano; Linda Jones; Farhan Javed; Nancy Murrah; Ngoc-Anh Le; Viola Vaccarino
Journal:  Atherosclerosis       Date:  2007-09-06       Impact factor: 5.162

2.  Influence of renin-angiotensin system gene polymorphisms on the risk of ST-segment-elevation myocardial infarction and association with coronary artery disease risk factors.

Authors:  Anna Konopka; Małgorzata Szperl; Walerian Piotrowski; Marta Roszczynko; Janina Stępińska
Journal:  Mol Diagn Ther       Date:  2011-06-01       Impact factor: 4.074

3.  The angiotensinogen gene M235T polymorphism and acute myocardial infarction risk: a meta-analysis of 22 studies.

Authors:  Xizhong Sui; Changqing Gao
Journal:  Mol Biol Rep       Date:  2013-05-13       Impact factor: 2.316

4.  The M235T polymorphism in the AGT gene and CHD risk: evidence of a Hardy-Weinberg equilibrium violation and publication bias in a meta-analysis.

Authors:  Mohammad Hadi Zafarmand; Yvonne T van der Schouw; Diederick E Grobbee; Peter W de Leeuw; Michiel L Bots
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

5.  Angiotensinogen-M235T as a risk factor for myocardial infarction in Asian populations: a genetic association study and a bioinformatics approach.

Authors:  Fariba Raygan; Mohammad Karimian; Atefeh Rezaeian; Bahareh Bahmani; Mohaddeseh Behjati
Journal:  Croat Med J       Date:  2016-08-31       Impact factor: 1.351

Review 6.  Omics era in forensic medicine: towards a new age

Authors:  Ramazan Akçan; Burak Taştekin; Mahmut Şerif Yildirim; Halit Canberk Aydogan; Necdet Sağlam
Journal:  Turk J Med Sci       Date:  2020-08-26       Impact factor: 0.973

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.